Oncologist. 2005 Aug;10(7):467-70.
The current situation: erlotinib (Tarceva) and gefitinib (Iressa) in non-small cell lung cancer.
Comis RL.
Drexel University College of Medicine, Clinical Trials Research Center, 1818 Market Street, Suite 1100, Philadelphia, PA 19013, USA. rcomis@ecogchair.org
PMID: 16079313 [PubMed - indexed for MEDLINE]
Publication Types:
MeSH Terms:
Substances:
Full Text Sources:
Medical: